1. DT‐01‐02: CONTINUED LARGE AMYLOID PET REDUCTIONS AT 36 MONTHS IN THE GANTENERUMAB OPEN‐LABEL EXTENSION STUDIES. (1st July 2019) Authors: Klein, Gregory; Delmar, Paul; Kerchner, Geoffrey A.; Hofmann, Carsten; Abi-Saab, Danielle; Ristic, Smiljana; Rehal, Sunita; Voyle, Nicola; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 28 Page Start: P1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O1‐09‐02: THE EFFECT OF LOW DOSES OF GANTENERUMAB ON AMYLOID AND TAU BIOMARKERS IN CEREBROSPINAL FLUID (CSF) IN THE MARGUERITE ROAD STUDY. (1st July 2006) Authors: Voyle, Nicola; Abi-Saab, Danielle; Klein, Gregory; Hofmann, Carsten; Delmar, Paul; Pross, Nathalie; Andjelkovic, Mirjana; Milosavljevic-Ristic, Smiljana; Martenyi, Ferenc; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O1‐09‐03: 24‐MONTH AMYLOID PET RESULTS OF THE GANTENERUMAB HIGH‐DOSE OPEN LABEL EXTENSION STUDIES. (1st July 2006) Authors: Klein, Gregory; Delmar, Paul; Hofmann, Carsten; Abi-Saab, Danielle; Andjelkovic, Mirjana; Ristic, Smiljana; Voyle, Nicola; Seibyl, John; Marek, Ken; Martenyi, Ferenc; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O1‐09‐04: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION (OLE) OF THE MARGUERITE ROAD STUDY IN PATIENTS WITH MILD ALZHEIMER'S DISEASE (AD) AFTER APPROXIMATELY TWO YEARS OF STUDY DURATION. (1st July 2006) Authors: Abi-Saab, Danielle; Andjelkovic, Mirjana; Pross, Nathalie; Delmar, Paul; Voyle, Nicola; Klein, Gregory; Esau, Nelli; Ristic, Smiljana; Martenyi, Ferenc; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O1‐09‐05: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION OF THE SCARLET ROAD STUDY IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE AFTER APPROXIMATELY 2 YEARS OF STUDY DURATION. (1st July 2006) Authors: Andjelkovic, Mirjana; Abi-Saab, Danielle; Delmar, Paul; Pross, Nathalie; Voyle, Nicola; Klein, Gregory; Mertes, Michaela; Ristic, Smiljana; Martenyi, Ferenc; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 4 Page Start: P241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. O3‐10‐01: CORRELATION BETWEEN AMYLOID REDUCTION AND CLINICAL OUTCOMES: EXPLORATORY ANALYSES FROM THE GANTENERUMAB SCARLET ROAD AND MARGUERITE ROAD OPEN‐LABEL EXTENSION STUDIES. (1st July 2019) Authors: Delmar, Paul; Kerchner, Geoffrey A.; Wang, Guoqiao; Bateman, Randall; Klein, Gregory; Rehal, Sunita; Voyle, Nicola; Andjelkovic, Mirjana; Abi-Saab, Danielle; Bullain, Szofia S.; Ristic, Smiljana; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 17 Page Start: P908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗